[THE ROLE OF TUMORAL STROMA IN PREDICTING OF THE SEVERITY COURSE IN PATIENTS, SUFFERING MAMMARY GLAND CANCER WITH P53 HYPEREXPRESSION].
There was revealed, that the survival indices in mammary gland cancer (MGC) patients in similar stage of the disease, in the same tumor histology, and in a mutant gene p53 hyperexpression, to whom identical complex treatment was conducted, are rhythmic, what witnesses a necessity to search for additional predicting factors. Predicting role of tumoral stroma in patients, suffering MGC with p53 hyperexpression, was studied.